Skip to main content
SpringerLink
Log in

Enzyme reduces toxic methotrexate levels

  • Media release
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. FDA.FDA Approves Voraxaze to Treat Patients With Toxic Methotrexate Levels. Media Release: 17 Jan 2012. Available from: URL: http://www.fda.gov

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Enzyme reduces toxic methotrexate levels. React. Wkly. 1386, 3 (2012). https://doi.org/10.2165/00128415-201213860-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201213860-00006

Keywords

Search

Navigation